Calamos Wealth Management LLC Purchases New Holdings in Cigna Group $CI

Calamos Wealth Management LLC purchased a new stake in shares of Cigna Group (NYSE:CI) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 15,825 shares of the health services provider’s stock, valued at approximately $4,221,000.

Several other institutional investors have also added to or reduced their stakes in CI. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group during the fourth quarter valued at approximately $25,000. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group during the 4th quarter worth approximately $28,000. Cedar Mountain Advisors LLC boosted its holdings in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the period. Kemnay Advisory Services Inc. bought a new position in Cigna Group in the 4th quarter valued at $29,000. Finally, Prosperity Bancshares Inc purchased a new stake in Cigna Group in the fourth quarter worth $29,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CI shares. Sanford C. Bernstein lifted their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday. Royal Bank Of Canada upped their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research note on Friday, May 1st. Wolfe Research reiterated an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Trading Up 3.8%

NYSE CI opened at $304.60 on Tuesday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a 50 day moving average price of $285.95 and a 200 day moving average price of $279.98. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market cap of $80.57 billion, a PE ratio of 12.91, a price-to-earnings-growth ratio of 1.13 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.0%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insiders Place Their Bets

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.